Biotechnology
First Subject Enrolled in Phase 1 Study of MRX-5
SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. (hereinafter referred to as ＂MicuRx＂) announced that its proprietary antibiotic MRX-5, has enrolled its first subject in the first Phase I clinical trial inAustralia. MRX-5 is a new type of benzodiazepine...
2023-11-20 18:34
1457
GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023
Recognized for its global-quality sample analysis services based on various analytical platforms YONGIN, South Korea, Nov. 20, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced onNovember 20th that it has been selected as the Top 10 Bioanalytical Services Prov...
2023-11-20 14:39
1432
Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.
SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform" is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capa...
2023-11-18 08:00
3082
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update
Conference call webcast is scheduled for November 22 at 9 a.m. ET.
SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited
2023-11-17 22:21
3765
Singleron Biotechnologies announces two co-authored abstracts at the American Society of Hematology conference
Using single cell multi-omics analysis to predict treatment outcome, develop
disease prognostics and track patient responses to CAR T therapies
COLOGNE, Germany, Nov. 17, 2023 /PRNewswire/ -- Singleron Biotechnologies
2023-11-17 17:58
1408
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange
HONG KONG, Nov. 17, 2023 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization ("CRDMO") focused on antibody drug conjugates ("ADC") and the broader bioconjugate market, listed on the...
2023-11-17 14:00
2981
Complete Genomics opens $3.2 million manufacturing facility at its San Jose headquarters
SAN JOSE, Calif., Nov. 16, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced plans for the opening of a$3.2 million manufacturing facility within its headquarters in San Jose, California. The facility, scheduled to open inMarch 2024, will give Comple...
2023-11-16 22:00
1687
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial
SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline results from the ACcomplisH China Phase 2 Trial in children with achondroplasia (ACH) aged 2 to 10 years. In the trial, ...
2023-11-16 22:00
1560
ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing
NEWARK, Del., Nov. 16, 2023 /PRNewswire/ -- ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, recently announces the launch of GMP grade DLL4. GMP grade DLL4 is a recombinant, soluble form of Delta-like Ligand 4, or DLL4, ...
2023-11-16 20:08
1429
Origin Agritech to Hold Business Update Conference Call on Tuesday, November 21 at 8 a.m. ET
BEIJING, Nov. 15, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, will host a conference call onTuesday, November 21, at 8:00 AM ET (9:00 PM Beijing Time) with the investment community to discuss the Company'...
2023-11-16 05:05
2122
Riding the tide, realize the future: The BD paths for Chinese Biotech
WUXI, China, Nov. 14, 2023 /PRNewswire/ -- 2023 BIO-Europe just closed last week. In line with previous conferences, this BD carnival attracted more than 2,000 companies, 5,000 attendees from close to 60 countries all over the world. Recently, we interviewed a global BD expert, Dr. Kaan Certel. ...
2023-11-15 10:42
1277
2023 World Laureates Association Prize winners awarded in Shanghai
SHANGHAI, Nov. 14, 2023 /PRNewswire/ -- The five winners of the 2023 World Laureates Association Prize (WLA Prize) received their awards for their ground-breaking achievements in computer science or mathematics and life science or medicine onNov. 6 at the opening ceremony of the 6th WLA Forum hel...
2023-11-15 09:54
3812
EDAN's Focus on Medical Technology Advancement Shines at MEDICA 2023
DUSSELDORF, Germany, Nov. 14, 2023 /PRNewswire/ -- Edan Instruments Inc.
2023-11-14 22:31
1732
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited
2023-11-14 20:47
1166
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
SYDNEY, Nov. 13, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage Australian biotech, is pleased to announce the appointment ofDamian Clarke-Bruce as Managing Director and CEO, effective13 November 2023. Outgoing CEO Bryce Carmine will remain active in the company, retaining his role as Cha...
2023-11-14 08:27
1348
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023
Direct evidence that BRII-179-induced functional antibody responses can contribute to increased and sustained HBsAg loss rate New insight in utilizing BRII-179 to enriching patients with intrinsic humoral immune responses for higher HBsAg loss or HBV functional cure rates New data support ...
2023-11-14 06:40
1574
OliPass Discloses Painful but Hilarious Clinical Findings from a Phase 2a Trial in OA Patients with Nav1.7 Selective Inhibitor OLP-1002
SEOUL, South Korea, Nov. 13, 2023 /PRNewswire/ -- OliPass Corporation, an RNA therapeutics platform company, disclosed uncanny clinical findings from a multi-center Phase 2a trial with Nav1.7 selective OLP-1002 in osteoarthritis (OA) patients with moderate to severe pain inAustralia with Novotech...
2023-11-13 22:00
1358
Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates
CAMBRIDGE, Mass., Nov. 13, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, today announced that it has entered into a strategic collaboration with GeneQuantum Healthcare to advance the early discovery of next-gener...
2023-11-13 16:04
1339
Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA
LEXINGTON, Mass., Nov. 11, 2023 /PRNewswire/ -- Fapon, a global leading life sciences organization, is thrilled to announce the grand opening of its US-based Research and Development (R&D) Center, strategically located in Lexington, Massachusetts. This Center represents Fapon's unwavering commitme...
2023-11-11 20:36
3086
MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results
SHENZHEN, China, Nov. 9, 2023 /PRNewswire/ -- On November 9, 2023, ImmVira announced the successful completion of Phase I clinical study conducted on late-stage patients with various tumor types for our intravenous oncolytic product, MVR-T3011 IV, inthe United States. This milestone was marked by...
2023-11-10 08:00
1869
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
